Purchase Order 75F40124P00106
Award Date 7/3/24
Potential Completion Date 7/4/25
Potential Value $360K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Bruker Biospin Corp, a manufacturer of scientific instruments, was awarded a firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration for $1,609,000. The contract calls for Bruker Biospin Corp to provide a 600 MHz Bruker nuclear magnetic resonance spectrometer to the agency's facility in Billerica, Massachusetts by December 31, 2022. No set-aside designation was used for this procurement. Bruker Corporation is the parent company of Bruker...
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the provision of nuclear magnetic resonance (NMR) equipment and services. The contract has a ceiling value of $1,334,738.00 and a period of performance ending on July 31, 2017. The contract was awarded on a full and open competition basis, with no set-aside designation. Bruker Biospin Corp is a manufacturer of advanced...
- The Department of Health and Human Services Food and Drug Administration awarded a $677,948.68 firm fixed price purchase order to Bruker Biospin Corp. to deliver a 400 MHz Nuclear Magnetic Resonance Spectrometer with solid and liquid probes. The solicitation sought this high-resolution NMR equipment to characterize pharmaceutical ingredients, drugs, and excipients in both liquid and solid states at the agency's Silver Spring, Maryland location. Installation, training, and maintenance services...
- The Department of Health and Human Services Food and Drug Administration awarded a $879,190.00 firm fixed price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, to upgrade the agency's 500 and 700 MHz nuclear magnetic resonance (NMR) spectrometers. The contract, which does not have a set-aside designation, will provide new equipment, including a new cryoprobe, backup room temperature probe, and automated sample changers, to improve the sensitivity and...
- The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp, a subsidiary of Bruker Corporation, a $110,097.30 firm-fixed-price purchase order to provide an automatic sample changer and compatible probe for a Bruker 400 MHz nuclear magnetic resonance (NMR) spectrometer. The award has an August 17, 2024 completion date and was made on September 16, 2022. Bruker Biospin Corp is a for-profit manufacturer of scientific instruments and equipment. The company...
- This is a $93,143.40 fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for a Bruker Avance III 500 MHz NMR service contract. The contract has a period of performance through September 16, 2021 and is not associated with a larger contract vehicle or set-aside designation. Bruker Biospin Corp is a provider of nuclear magnetic resonance (NMR) spectrometers, maintenance, and support services to...
- This is a $159,767.50 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for the provision of a Bruker Avance III 500 MHz Nuclear Magnetic Resonance (NMR) system. The contract has no set-aside designation and is for the service and maintenance of this specialized scientific equipment used by the FDA. Bruker Biospin Corp has a history of providing NMR systems, upgrades, and support services...
- The U.S. Food and Drug Administration (FDA) awarded a $195,933.11 firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, to acquire a comprehensive service agreement from the original equipment manufacturer (OEM) Bruker. The agreement includes preventive maintenance with two (2) helium refills per year, as well as any repairs and support for a Bruker Avance III HD 600 instrument. The award has an ultimate completion date of August 31, 2027. Bruker...
- The Department of Health and Human Services Food and Drug Administration awarded a $126,772 firm fixed price purchase order to Bruker Biospin Corp. to deliver a solid-state NMR probe. The place of performance is in Billerica, Massachusetts, with work expected to be completed by April 2024. Per the solicitation, the FDA requested quotes for a solid-state NMR probe to add to an existing 500-MHz instrument in order to expand its analytical capabilities. As the leading regulatory agency for ensuring...
- This federal contract award was issued by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for the procurement of a Quadruple Resonance Inverse (QCI) Detection Cryoprobe for high-field nuclear magnetic resonance (NMR) instrumentation. The contract, valued at $315,583.00, was awarded on a firm fixed-price basis without any set-aside designation. The award supports the FDA's 850 MHz Instrument Cryoprobe program, which focuses on advanced analytical...